Drugs, Devices, and Diagnostics
Latest | Media coverage | Commentary | Academic Literature | Legislation | Reports and Government Documents
Covering prescription medicines and medical devices, which includes instruments, implants, scans and tests, as well as screening and health promoting interventions.
Latest
Media coverage
David Seymour’s ‘whole of society’ plan for tipping millions of dollars more in to Pharmac – and Big Pharma
The very idea of Pharmac presents a conundrum for the minister in charge, Act leader David Seymour.
Most high-income countries ban direct advertising of prescription drugs – why does NZ still allow it?
New Zealand and the United States are the only high-income countries to allow unrestricted direct-to-consumer advertising of branded medicines, including the name of the drug and the condition for which it is prescribed.
Health New Zealand backtracks on Keytruda delay, will allow early access to some patients
Health New Zealand Te Whatu Ora has backed down on a plan to delay free access to a life-extending cancer drug after a backlash by patients and advocates.
Commentary
Funding to Māori Health Providers 2018/19 to 2022/23
This report shows information on funding to Māori health providers by the Ministry of Health, Te Whatu Ora and Te Aka whai Ora for the period 2018/19 to 2022/23. This report follows on from our reports in 2017, 2021 and 2022 on the same topic and is part of our monitoring of Whakamaua: Māori Health Action Plan 2020-2053.
Wai 2575 Health Services and Outcomes Inquiry
The Waitangi Tribunal’s Health Service and Outcomes Inquiry (Wai 2575) is an inquiry into the Crown’s response to health inequities experienced by Māori.
Academic Literature
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Legislation and Parliament
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Reports and Government Documents
Misuse of Drugs (Pseudoephedrine) Amendment Bill
Health Committee. In accordance with the Government’s commitment to allow the sale of cold and flu medication containing pseudoephedrine, the purpose of this Bill is to change the classification of pseudoephedrine as a controlled drug. This Bill reclassifies...
Revised Code of Practice for Diagnostic and Interventional Radiology ORS C1
The Radiation Safety Act 2016 (the Act) is administered by the Manatū Hauora – the Ministry of Health (the Ministry). Section 86(1) of the Act allows the Director for Radiation Safety (Director) to issue codes of practice. This is for the purpose of specifying technical requirements.
Cabinet material: Amendments to prescribing regulations for controlled drugs
Cabinet papers:
Amendments to prescribing regulations for controlled drugs
Misuse of Drugs Amendment Regulations
Key issues
HEALTH SERVICES AND SYSTEMS
EQUITY
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI